(Q39393253)

11 September 2017

1 reference

title

Current progress in host innate and adaptive immunity against hepatitis C virus infection (English)

1 reference

11 September 2017

1 reference

Jijing Shi

1

1 reference

11 September 2017

Yuanyuan Li

2

1 reference

11 September 2017

Wenxian Chang

3

1 reference

11 September 2017

Xuexiu Zhang

4

1 reference

11 September 2017

Fu-Sheng Wang

5

1 reference

11 September 2017

publication date

22 June 2017

1 reference

11 September 2017

published in

Hepatology international

1 reference

11 September 2017

volume

11

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

374-383

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

11 September 2017

1 reference

HCV in 2015: Advances in hepatitis C research and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Prevention of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Immune responses and immunopathology in acute and chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Protective immunity against hepatitis C: many shades of gray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Long-term follow-up after successful interferon therapy of acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Host genetic variants influencing the clinical course of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Interferon-Mediated Cytokine Induction Determines Sustained Virus Control in Chronic Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Direct-Acting Antivirals Cure Innate Immunity in Chronic Hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Role of T cell immunity in hepatitis C virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

CD39 Expression Identifies Terminally Exhausted CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Immune regulation in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Intact dendritic cell pathogen-recognition receptor functions associate with chronic hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Myeloid dendritic cells can kill T cells during chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Inflammation and repair in viral hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Clinical implications of chemokines in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Inflammasome activation and function in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Trace amounts of sporadically reappearing HCV RNA can cause infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Restoration of HCV-specific CD8+ T cell function by interferon-free therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Augmentation of hepatitis C virus-specific immunity and sustained virologic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-017-9805-2

Chronic hepatitis C infection blocks the ability of dendritic cells to secrete IFN-α and stimulate T-cell proliferation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28643186

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12072-017-9805-2

1 reference

11 September 2017

1 reference